PharmaShots | Incisive News in 3 Shots

Subscribe Now

Boehringer Ingelheim

Boehringer Ingelheim Introduces Vetmedin Solution (Pimobendan Oral Solution), for Congestive Heart Failure in Dogs

Boehringer Ingelheim Introduces Vetmedin Solution (Pimobendan Oral Solution), for Congestive Heart Failure in Dogs

November 28, 2024

Boehringer Ingelheim Join Forces with Circle Pharma to Develop a Novel Precision Cancer Treatment

Boehringer Ingelheim Join Forces with Circle Pharma to Develop a Novel Precision Cancer Treatment

October 10, 2024

Boehringer Ingelheim Reports the P-III (FIBRONEER-IPF) Trial Data of Nerandomilast to Treat Idiopathic Pulmonary Fibrosis (IPF)

Boehringer Ingelheim Reports the P-III (FIBRONEER-IPF) Trial Data of Nerandomilast to Treat Idiopathic Pulmonary Fibrosis (IPF)

September 20, 2024

Boehringer Ingelheim Reports the Acquisition of Saiba Animal Health, Strengthening its R&D Portfolio Focusing on Animal Health

Boehringer Ingelheim Reports the Acquisition of Saiba Animal Health, Strengthening its R&D Portfolio Focusing on Animal Health

September 3, 2024

Boehringer Ingelheim Reports the Acquisition of Nerio Therapeutics for $1.3B

Boehringer Ingelheim Reports the Acquisition of Nerio Therapeutics for $1.3B

July 31, 2024

Boehringer Ingelheim Reports Additional Data from the P-II Study of Survodutide to Treat Metabolic Dysfunction-Associated Steatohepatitis (MASH)

Boehringer Ingelheim Reports Additional Data from the P-II Study of Survodutide to Treat Metabolic Dysfunction-Associated Steatohe...

June 7, 2024

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us